Login / Signup

A zebrafish model of tuberculosis comorbidity and the effects of HIF-activating intervention.

Stefan H OehlersElinor HortleKristina M Cook
Published in: The FEBS journal (2020)
Comorbidities are an important factor in tuberculosis pathophysiology and treatment but are understudied in animal models. Schild et al. present a zebrafish model of Mycobacterium marinum infection and wound comorbidity that retains responsiveness to protective hypoxia-inducible factor-1α activation as an example of a host-directed therapy. This platform is a new paradigm for the zebrafish-M. marinum infection model and provides a blueprint to test therapeutic interventions on infection and comorbid pathologies. Comment on: https://doi.org/10.1111/febs.15433.
Keyphrases
  • mycobacterium tuberculosis
  • randomized controlled trial
  • stem cells
  • pulmonary tuberculosis
  • emergency department
  • physical activity
  • high throughput
  • mesenchymal stem cells
  • bone marrow
  • adverse drug
  • cell therapy